{"id":58703,"date":"2024-01-11T13:03:03","date_gmt":"2024-01-11T12:03:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/"},"modified":"2024-01-11T13:03:03","modified_gmt":"2024-01-11T12:03:03","slug":"verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/","title":{"rendered":"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference"},"content":{"rendered":"
\n

BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM) (the \u201cCompany), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company will participate in a fireside chat at the B. Riley Securities 4th<\/sup> Annual Oncology Conference on Thursday, January 18, 2024 at 4:00 p.m. ET.<\/p>\n

<\/a>
<\/a><\/p>\n

\nTo access the live webcast of the fireside chat, please contact your B. Riley Securities sales representative.<\/p>\n

\nFollowing the event, an archived replay of the fireside chat will be available on the investors section of the Company\u2019s website at www.verastem.com<\/a>.<\/p>\n

\nAbout Verastem Oncology<\/b><\/p>\n

\nVerastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF\/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:<\/b>
Ryan Porter
\n
Argot Partners
\n
+1 212-600-1902
\n
ryan.porter@argotpartners.com<\/a><\/p>\n

\nMedia:<\/b>
Lisa Buffington
\n
Corporate Communications
\n
+1 781-292-4502
\n
lbuffington@verastem.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM) (the \u201cCompany), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference on Thursday, January 18, 2024 at 4:00 p.m. ET. To access the live webcast of the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58703","6":"format-standard","7":"category-industry"},"yoast_head":"\nVerastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM) (the \u201cCompany), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference on Thursday, January 18, 2024 at 4:00 p.m. ET. To access the live webcast of the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-11T12:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240111104814\/en\/1992573\/21\/Verastem_logo_v2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference\",\"datePublished\":\"2024-01-11T12:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/\"},\"wordCount\":198,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240111104814\\\/en\\\/1992573\\\/21\\\/Verastem_logo_v2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/\",\"name\":\"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240111104814\\\/en\\\/1992573\\\/21\\\/Verastem_logo_v2.jpg\",\"datePublished\":\"2024-01-11T12:03:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240111104814\\\/en\\\/1992573\\\/21\\\/Verastem_logo_v2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240111104814\\\/en\\\/1992573\\\/21\\\/Verastem_logo_v2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/","og_locale":"en_US","og_type":"article","og_title":"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference - Pharma Trend","og_description":"BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM) (the \u201cCompany), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference on Thursday, January 18, 2024 at 4:00 p.m. ET. To access the live webcast of the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/","og_site_name":"Pharma Trend","article_published_time":"2024-01-11T12:03:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240111104814\/en\/1992573\/21\/Verastem_logo_v2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference","datePublished":"2024-01-11T12:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/"},"wordCount":198,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240111104814\/en\/1992573\/21\/Verastem_logo_v2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/","url":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/","name":"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240111104814\/en\/1992573\/21\/Verastem_logo_v2.jpg","datePublished":"2024-01-11T12:03:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240111104814\/en\/1992573\/21\/Verastem_logo_v2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240111104814\/en\/1992573\/21\/Verastem_logo_v2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/verastem-oncology-to-participate-in-the-b-riley-securities-4th-annual-oncology-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58703"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58703\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}